The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.

Claims

9 · 2 independent · depth 3

9 granted claims

›1.independentA method of treating an autoimmune disorder in a patient comprising administering to said patient an effective amount therefor of an efomycin of the f…+2

›2.independentA compound selected from the group consisting of: a) Efomycin M of the formula (Ia): ##STR11## and b) Efomycin T of the formula (Ib): ##STR12##+5

Classifications

2 codes

USPC · US Patent Classification

514/450549/267

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency

2.1 y

781 days filing → grant

Office actions

on the grant's record

Examiner

Ba K. Trinh

art unit —

Law firm

Law firm · Log in to unlock

Citations: 8 back · 0 forward

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.